Page last updated: 2024-09-03

olmesartan medoxomil and Atrial Fibrillation

olmesartan medoxomil has been researched along with Atrial Fibrillation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Breithardt, G; Fetsch, T; Goette, A; Hanrath, P; Klein, HU; Lehmacher, W; Meinertz, T; Steinbeck, G	1

Trials

1 trial(s) available for olmesartan medoxomil and Atrial Fibrillation

Article	Year
Angiotensin II antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial: rationale and study design. Clinical drug investigation, 2007, Volume: 27, Issue:10 Topics: Angiotensin II Type 1 Receptor Blockers; Atrial Fibrillation; Biometry; Double-Blind Method; Electrocardiography; Endpoint Determination; Follow-Up Studies; Humans; Imidazoles; Olmesartan Medoxomil; Prospective Studies; Research Design; Telemedicine; Tetrazoles	2007

Article

Year

Angiotensin II antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial: rationale and study design.

Clinical drug investigation, 2007, Volume: 27, Issue:10

Topics: Angiotensin II Type 1 Receptor Blockers; Atrial Fibrillation; Biometry; Double-Blind Method; Electrocardiography; Endpoint Determination; Follow-Up Studies; Humans; Imidazoles; Olmesartan Medoxomil; Prospective Studies; Research Design; Telemedicine; Tetrazoles

2007